AgeBiotics AB-01
Asset
- Stage
- Phase 2
- Modality
- Supplement
- Target
- Not known
- 0
- Indications
- 1
- Trial
- 1
- Developer
Indications
1No named disease
Phase 2, Completed, NCT07871799, clinicaltrials.gov, 15 Oct 2026
In the full profile
- Owner and partners1
- Trials1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.